Zevra Therapeutics, Inc. (ZVRA)
9.99
-0.19
(-1.87%)
USD |
NASDAQ |
Oct 02, 16:00
9.975
-0.02
(-0.15%)
After-Hours: 20:00
Zevra Therapeutics Market Cap : 592.83M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 592.83M |
| October 01, 2026 | 604.10M |
| September 30, 2026 | 650.98M |
| September 29, 2026 | 672.94M |
| September 28, 2026 | 670.56M |
| September 25, 2026 | 655.13M |
| September 24, 2026 | 668.19M |
| September 23, 2026 | 671.75M |
| September 22, 2026 | 687.18M |
| September 21, 2026 | 692.52M |
| September 18, 2026 | 688.96M |
| September 17, 2026 | 702.61M |
| September 16, 2026 | 700.23M |
| September 15, 2026 | 691.33M |
| September 14, 2026 | 715.07M |
| September 11, 2026 | 712.70M |
| September 10, 2026 | 715.66M |
| September 09, 2026 | 714.48M |
| September 08, 2026 | 752.16M |
| September 04, 2026 | 735.84M |
| September 03, 2026 | 744.15M |
| September 02, 2026 | 729.91M |
| September 01, 2026 | 715.66M |
| August 31, 2026 | 696.67M |
| August 28, 2026 | 686.29M |
| Date | Value |
|---|---|
| August 27, 2026 | 703.20M |
| August 26, 2026 | 696.67M |
| August 25, 2026 | 714.48M |
| August 24, 2026 | 691.33M |
| August 21, 2026 | 704.39M |
| August 20, 2026 | 705.58M |
| August 19, 2026 | 719.82M |
| August 18, 2026 | 686.59M |
| August 17, 2026 | 684.21M |
| August 14, 2026 | 671.75M |
| August 13, 2026 | 663.44M |
| August 12, 2026 | 678.87M |
| August 11, 2026 | 672.94M |
| August 10, 2026 | 681.24M |
| August 07, 2026 | 685.99M |
| August 06, 2026 | 704.98M |
| August 05, 2026 | 624.87M |
| August 04, 2026 | 624.28M |
| August 03, 2026 | 596.68M |
| July 31, 2026 | 562.18M |
| July 30, 2026 | 569.87M |
| July 29, 2026 | 578.14M |
| July 28, 2026 | 575.19M |
| July 27, 2026 | 574.00M |
| July 24, 2026 | 563.07M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Innoviva, Inc. | 1.489B |
| Johnson & Johnson | 616.58B |
| Ligand Pharmaceuticals, Inc. | 6.035B |
| Collegium Pharmaceutical, Inc. | 715.61M |
| Xeris Biopharma Holdings, Inc. | 1.576B |
Market Cap Related Metrics
| PE Ratio | 10.78 |
| PS Ratio | 4.361 |
| Price to Book Value | 2.724 |
| Price to Free Cash Flow | 18.19 |
| Price | 9.99 |
| Earnings Yield | 9.28% |
| Operating PE Ratio | 15.19 |
| Normalized PE Ratio | 8.806 |